Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer
- 287 Downloads
The aim of the study was to assess the validity, reliability and sensitivity of the FACT-P (version 4) in Chinese males with prostate cancer.
Construct validity was assessed using Spearman’s correlation test against the 12-item Short Form Health Survey (SF-12v2). Internal consistency and test–retest reliability were assessed using Cronbach’s α coefficient and intra-class correlation coefficient, respectively. Sensitivity was determined by performing known-group comparisons by independent t test.
FACT-P subscale scores had a moderate correlation with the corresponding SF-12v2 domain score that conceptually measures the similar construct providing evidence for adequate construct validity. Internal consistency was acceptable (α: 0.687–0.900) for all subscales aside from the Prostate Cancer Subscale (α: 0.505) and Trial Outcome Index (α: 0.562). FACT-P subscale and total scores showed good test–retest reliability (range 0.753–0.913). All total scales and most of the subscales were sensitive in detecting differences between patients with different levels of functional impairment but not different cancer stages or levels of prostate-specific antigen.
The measure is a valid and reliable measure to assess the health-related quality of life of Chinese males with prostate cancer. The FACT-P is sensitive to detect difference between patients with varying functional status.
KeywordsQuality of life Psychometrics Validity Reliability Prostate cancer Chinese
The authors wish to express their gratitude to Professor Cindy Lam for design and planning of this study, Charles Wong for his assistance in data collection and Anca Chan for his help in performing statistical analyses.
Ethics approval of the study protocol was obtained from the Institutional Review Board of the University of Hong Kong and Hospital Authority (Ref No.: UW13-239).
- 3.Miller, D. C., Sanda, M. G., Dunn, R. L., Montie, J. E., Pimentel, H., Sandler, H. M., et al. (2005). Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology, 23(12), 2772–2780.CrossRefPubMedGoogle Scholar
- 5.Schmidt, S., Garin, O., Pardo, Y., Valderas, J., Alonso, J., Rebollo, P., et al. (2014). Assessing quality of life in patients with prostate cancer: A systematic and standardized comparison of available instruments. Quality of Life Research, 23(8), 2169–2181.PubMedCentralCrossRefPubMedGoogle Scholar
- 13.Yu, C. L. M., Fielding, R., Chan, C. L. W., Tse, V. K. C., Choi, P. H. K., Lau, W. H., Choy, D. T. K., Lee, A. W. M., & Sham, J. S. T. (2000). Measuring quality of life of Chinese cancer patients. Cancer, 88(7), 1715–1727. Google Scholar
- 14.Wong, C. K. H., Lam, C. L. K., Law, W. L., Poon, J. T. C., Chan, P., Kwong, D. L. W., & Tsang, J. (2012). Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. Journal of Evaluation in Clinical Practice, 18(6), 1186–1195.Google Scholar
- 15.Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86.Google Scholar
- 17.Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.Google Scholar
- 19.Churchill, G. A., Jr. (1979). A paradigm for developing better measures of marketing constructs. Journal of marketing research, 16(1), 64–73.Google Scholar
- 22.Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., et al. (2010). Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology, 28(34), 5038–5045.CrossRefPubMedGoogle Scholar
- 23.Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009). Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer and Prostatic Diseases, 12(2), 198–203.CrossRefPubMedGoogle Scholar